Nouri K - Search Results

1

Involvement of Hippocampal D1-Like Dopamine Receptors in the Inhibitory Effect of Cannabidiol on Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference.

Nouri K, Anooshe M, Karimi-Haghighi S, Mousavi Z, Haghparast A. Nouri K, et al. Neurochem Res. 2021 Aug;46(8):2008-2018. doi: 10.1007/s11064-021-03350-w. Epub 2021 May 15. Neurochem Res. 2021. PMID: 33993443

2

Cannabidiol efficiently suppressed the acquisition and expression of methamphetamine-induced conditioned place preference in the rat.

Anooshe M, Nouri K, Karimi-Haghighi S, Mousavi Z, Haghparast A. Anooshe M, et al. Among authors: nouri k. Behav Brain Res. 2021 Apr 23;404:113158. doi: 10.1016/j.bbr.2021.113158. Epub 2021 Feb 8. Behav Brain Res. 2021. PMID: 33571569

3

Protective effects of curcumin against traumatic brain injury.

Khayatan D, Razavi SM, Arab ZN, Niknejad AH, Nouri K, Momtaz S, Gumpricht E, Jamialahmadi T, Abdolghaffari AH, Barreto GE, Sahebkar A. Khayatan D, et al. Among authors: nouri k. Biomed Pharmacother. 2022 Oct;154:113621. doi: 10.1016/j.biopha.2022.113621. Epub 2022 Aug 30. Biomed Pharmacother. 2022. PMID: 36055110 Free article. Review.

4

The palliative role of lasers in the treatment of melanoma.

Algarin YA, Pulumati A, Jaalouk D, Tan J, Zeitouni NC, Nouri K. Algarin YA, et al. Among authors: nouri k. Arch Dermatol Res. 2024 May 25;316(6):244. doi: 10.1007/s00403-024-03107-9. Arch Dermatol Res. 2024. PMID: 38795247 Review.

5

A retrospective analysis of drugs associated with the development of cutaneous squamous cell carcinoma reported by patients on the FDA's adverse events reporting system.

Jean-Pierre P, Nouri K. Jean-Pierre P, et al. Among authors: nouri k. Arch Dermatol Res. 2024 May 25;316(6):250. doi: 10.1007/s00403-024-03109-7. Arch Dermatol Res. 2024. PMID: 38795220

6

Demographic disparities and survival rates in cutaneous appendageal carcinomas.

Desai AD, Pulumati AL, Ragi SD, Eckembrecher DG, Eckembrecher FJ, Nouri K. Desai AD, et al. Among authors: nouri k. Arch Dermatol Res. 2024 May 22;316(5):200. doi: 10.1007/s00403-024-02995-1. Arch Dermatol Res. 2024. PMID: 38775834 No abstract available.

7

Addressing disparities: a cross-sectional analysis of diversity in Merkel cell carcinoma clinical trials.

Pulumati A, Algarin YA, Kim S, Nouri K. Pulumati A, et al. Among authors: nouri k. Arch Dermatol Res. 2024 May 17;316(5):178. doi: 10.1007/s00403-024-02935-z. Arch Dermatol Res. 2024. PMID: 38758392 No abstract available.

8

Examining the association of non-melanoma skin cancer with immunomodulatory conditions: a cross-sectional analysis of the All of Us database.

Jean-Pierre P, Nouri K. Jean-Pierre P, et al. Among authors: nouri k. Arch Dermatol Res. 2024 May 11;316(5):161. doi: 10.1007/s00403-024-02921-5. Arch Dermatol Res. 2024. PMID: 38734810 No abstract available.

9

Beyond the Label: Real-World Side Effects Experienced With FDA-Approved Drugs for Non-Melanoma Skin Cancers.

Ravipati A, Pradeep T, Nouri K. Ravipati A, et al. Among authors: nouri k. J Drugs Dermatol. 2024 May 1;23(5):301-305. doi: 10.36849/JDD.7968. J Drugs Dermatol. 2024. PMID: 38709693

10

3D bioprinting: a review and potential applications for Mohs micrographic surgery.

Pulumati A, Algarin YA, Kim S, Latta S, Li JN, Nouri K. Pulumati A, et al. Among authors: nouri k. Arch Dermatol Res. 2024 May 2;316(5):147. doi: 10.1007/s00403-024-02893-6. Arch Dermatol Res. 2024. PMID: 38698273 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page